Immune checkpoint inhibitors in malignant pleural mesothelioma: promises and challenges

被引:8
|
作者
Ceresoli, Giovanni Luca [1 ]
Bonomi, Maria [1 ]
Sauta, Maria Grazia [1 ]
机构
[1] Clin Humanitas Gavazzeni, Thorac & GU Oncol Unit, Dept Med Oncol, I-24125 Bergamo, Italy
关键词
Malignant pleural mesothelioma; immunotherapy; immune-checkpoint inhibitors; SINGLE-ARM; OPEN-LABEL; TREMELIMUMAB; CISPLATIN; BLOCKADE; PHASE-2; CANCER; SAFETY;
D O I
10.1080/14737140.2016.1191951
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:673 / 675
页数:3
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma
    Metro, Giulio
    Signorelli, Diego
    Pizzutilo, Elio G.
    Giannetta, Laura
    Cerea, Giulio
    Garaffa, Miriam
    Friedlaender, Alex
    Addeo, Alfredo
    Mandarano, Martina
    Bellezza, Guido
    Roila, Fausto
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (09) : 2972 - 2980
  • [2] The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma
    Borgeaud, Maxime
    Kim, Floryane
    Friedlaender, Alex
    Lococo, Filippo
    Addeo, Alfredo
    Minervini, Fabrizio
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [3] Immune checkpoint inhibitor therapy for malignant pleural mesothelioma
    Nowak, Anna K.
    Chin, Wee Loong
    Keam, Synat
    Cook, Alistair
    LUNG CANCER, 2021, 162 : 162 - 168
  • [4] Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-Analysis
    Gemelli, Maria
    Cortinovis, Diego Luigi
    Baggi, Alice
    di Mauro, Pierluigi
    Calza, Stefano
    Berruti, Alfredo
    Grisanti, Salvatore
    Rota, Matteo
    CANCERS, 2022, 14 (24)
  • [5] Immune checkpoint inhibitors in malignant pleural mesothelioma
    Ceresoli, Giovanni Luca
    Mantovani, Alberto
    LANCET ONCOLOGY, 2017, 18 (05) : 559 - 561
  • [6] Immune Checkpoint Inhibition for Unresectable Malignant Pleural Mesothelioma
    Cui, Wanyuan
    Popat, Sanjay
    DRUGS, 2021, 81 (09) : 971 - 984
  • [7] Success of Checkpoint Blockade Paves the Way for Novel Immune Therapy in Malignant Pleural Mesothelioma
    Rondon, Lizbeth
    Fu, Roberto
    Patel, Manish R.
    CANCERS, 2023, 15 (11)
  • [8] True Benefits of Immune Checkpoint Inhibitors in the Treatment of Malignant Pleural Mesothelioma in Japan
    Kuribayashi, Kozo
    Hirano, Jun
    ANTICANCER RESEARCH, 2024, 44 (10) : 4135 - 4145
  • [9] Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study
    Assie, Jean-Baptiste
    Crepin, Florian
    Grolleau, Emmanuel
    Canellas, Anthony
    Geier, Margaux
    Grebert-Manuardi, Aude
    Akkache, Nabila
    Renault, Aldo
    Hauss, Pierre-Alexandre
    Sabatini, Marielle
    Bonnefoy, Valentine
    Cortot, Alexis
    Wislez, Marie
    Gauvain, Clement
    Chouaid, Christos
    Scherpereel, Arnaud
    Monnet, Isabelle
    CANCERS, 2022, 14 (06)
  • [10] Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma
    Hotta, Katsuyuki
    Fujimoto, Nobukazu
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)